Literature DB >> 21392452

Mycobacterium caprae infection in livestock and wildlife, Spain.

Sabrina Rodríguez1, Javier Bezos, Beatriz Romero, Lucía de Juan, Julio Álvarez, Elena Castellanos, Nuria Moya, Francisco Lozano, M Tariq Javed, José L Sáez-Llorente, Ernesto Liébana, Ana Mateos, Lucas Domínguez, Alicia Aranaz.   

Abstract

Mycobacterium caprae is a pathogen that can infect animals and humans. To better understand the epidemiology of M. caprae, we spoligotyped 791 animal isolates. Results suggest infection is widespread in Spain, affecting 6 domestic and wild animal species. The epidemiology is driven by infections in caprids, although the organism has emerged in cattle.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392452      PMCID: PMC3165998          DOI: 10.3201/eid1703.100618

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Mycobacterium caprae is a cluster within the M. tuberculosis complex (Technical Appendix). This pathogen has been recognized mainly in central Europe, where it has been occasionally isolated from tuberculous lesions from cattle (–), pigs (), red deer (Cervus elaphus) (,), and wild boars (Sus scrofa) (). Its isolation from humans has also been described (,); often, a contact with livestock has been suggested as a likely means of transmission (). To our knowledge, this pathogen has never been isolated outside continental Europe, except from a European patient in Australia () and a cow in Algeria (). The combination of disease tracing and molecular typing is needed to understand the epidemiology of tuberculosis. This report describes the molecular epidemiology of M. caprae infection in Spain compared with other countries. We characterized M. caprae isolates from goats and other domestic and wild animals by spoligotyping (). The relative contribution of each animal and its role in animal tuberculosis are discussed.

The Study

This study included 791 M. caprae isolates from domestic goats (Capra aegagrus hircus, n = 542), sheep (Ovis aries, n = 2), cattle (Bos taurus, n = 229), domestic pigs (Sus scrofa domestica, n = 2), wild boars (Sus scrofa, n = 14), red deer (Cervus elaphus, n = 1), and a fox (Vulpes vulpes, n = 1). The samples originated from skin test–positive animals identified within the national or regional eradication programs, from abattoir surveillance, and from postmortem inspections of wildlife, and were collected from 1992 through June 2009 in different geographic areas in Spain (Figure 1). Spoligotyping was performed as described (), and authoritative names for spoligotype patterns were obtained from the Mycobacterium bovis Spoligotype Database (www.mbovis.org).
Figure 1

Map of Spain showing the distribution of the 2 most frequent Mycobacterium caprae spoligotypes and affected animals: C, cattle; D, red deer; F, fox; G, goats; S, sheep; P, pigs; WB, wild boar. A) Spoligotype SB0157. B) Spoligotype SB0416.

Map of Spain showing the distribution of the 2 most frequent Mycobacterium caprae spoligotypes and affected animals: C, cattle; D, red deer; F, fox; G, goats; S, sheep; P, pigs; WB, wild boar. A) Spoligotype SB0157. B) Spoligotype SB0416. Further authentication was achieved by detection of RD4 in the isolates with a 3-primer PCR in a panel of 63 unrelated isolates that included all spoligotyping patterns and animal species. Of the selected isolates, 62 showed the 545-bp product, indicating that they harbor RD4. One isolate from a cow of Eastern European origin repeatedly showed a 340-bp band, and its sequencing could not confirm presence or absence of RD4. For detection of specific M. caprae gene polymorphisms, 1 isolate from every spoligotyping pattern was studied. Additional identification was determined by sequencing of the pyrazinamidase A gene, which demonstrated a C at nt 169 that results in the functional wild-type pyrazinamidase A gene, and of the gyrase B gene that showed the G at nt 1311 and a C at position 1410 (Technical Appendix). The isolates, which originated from 195 single cases or outbreaks (Table 1), clustered into 15 patterns, which share the features previously described for the species (absence of spacers 1, 3–16, 28, and 39–43). Notably, the Iberian spoligotype cluster lacks spacers 30–33, whereas most M. caprae isolates from central Europe belong to spoligotypes that harbor these spacers. The 3 isolates of profiles SB0418 and SB1619 that presented spacers 30–33 originated from cattle imported from southeastern Europe. The 2 predominant spoligotypes, SB0157 and SB0416, were found to be responsible for 60% and 22%, respectively, of the cases and infected different animal species in distant areas, whereas 7 patterns were unique to a single case or outbreak. We calculated the index of discrimination (D) described by Hunter and Gaston () using the website of the University of the Basque Country (www.insilico.ehu.es). The result, D = 0.584, is notably lower compared with a parallel research of 252 patterns from 6,215 M. bovis isolates (D = 0.87) ().
Table 1

Spoligotyping results of 791 Mycobacterium caprae isolates and their distribution within different animal species, Spain, 1992–2009*

Ref
Spoligotyping pattern†
No. animals (no. outbreaks)
Goats
Sheep
Cattle
Pigs
Wild
boar
Red
deer
Fox
SB0157□■□□□□□□□□□□□□□□■■■■■□□■■■■□■□□□□■■■■■□□□□□204 (44)1133 (67)14 (4)1
SB0415□■□□□□□□□□□□□□□□■■□■■■■■■■■□■□□□□■■■■■□□□□□37 (4)18 (4)4 (3)
SB0416□■□□□□□□□□□□□□□□■■■■■■■■■■■□■□□□□■■■■■□□□□□80 (18)58 (21)5 (3)1
SB0866□■□□□□□□□□□□□□□□■■■■■■■■□□□□□□□□□□□□□□□□□□□111
SB0973□□□□□□□□□□□□□□□□■■■■■□□■■■■□■□□□□□■□■■□□□□□1
SB1077□■□□□□□□□□□□□□□□■■■■■■■■■□□□■□□□□■■■■■□□□□□17 (4)1
SB1078□■□□□□□□□□□□□□□□■■■■□□□■■■■□■□□□□■■■■■□□□□□11
SB1079□□□□□□□□□□□□□□□□■■■■□□□■■■■□■□□□□□■□■■□□□□□1
SB1080□■□□□□□□□□□□□□□□■■■■■■■■■■□□■□□□□■■■■■□□□□□2 (1)
SB1081□■□□□□□□□□□□□□□□■■■■■□□■□□□□□□□□□□□□□□□□□□□18 (4)
SB1084□■□□□□□□□□□□□□□□■■□■■■■□■■■□■□□□□■■■■■□□□□□211 (1)
SB1889□■□□□□□□□□□□□□□□■■□■■■■□□□□□□□□□□□□□□□□□□□□2 (1)
SB1872□□□□□□□□□□□□□□□□□□■■■□□■■■■□■□□□□■■■■■□□□□□1
SB0418□■□□□□□□□□□□□□□□■■■■■■■■■■■□■■■■■■■■■■□□□□□2 (2)
SB1690
□■□□□□□□□□□□□□□□■■■■■■□■■■■□■■■■■■■■■■□□□□□


1




Total542 
(75)2 
(2)229 (105)2 
(2)14 (11)11

*Ref, reference. Numbering according to www.Mbovis.org.
†■, presence of spacer ; □, absence of spacer.

*Ref, reference. Numbering according to www.Mbovis.org.
†■, presence of spacer ; □, absence of spacer. Additionally, variable number tandem repeat typing by using loci ETR-A, ETR-B, ETR-D, QUB11a, QUB11b, QUB3232, ETR-E, and MIRU26 ( Technical Appendix) was performed as described by Frothingham and Meeker-O’Connell () on a selection of 20 isolates (Table 2). The isolates originated from 10 properties (6 goat herds and 4 cattle farms), each with 2 different spoligotypes detected at a time. At 5 farms, the loss of spacers 25–27, 29, and 34–38, which can be explained by a single deletion event, had caused a change of the spoligotype pattern. This loss changed SB0157 to SB1081 and SB1084 to SB1889, while the variable number tandem repeat profiles within the same farm remained identical.
Table 2

Variable number tandem repeat analysis of isolates from 10 farms that presented mixed Mycobacterium caprae infection (different spoligotype patterns), Spain, 1992–2009*

FarmAnimalSpoligotypeNo. alleles at locus
ETR-AETR-BETR-DQUB3232QUB 11aQUB 11bMIRU 26MIRU 31
1
Goat
SB041644487252
SB0866
5
3
3
8
7
4
2
4
2
Goat
SB041643487242
SB0157
4
3
4
8
7
2
4
2
3
Goat
SB041645576455
SB0415
5
1
3
8
7
3
5
5
4
Cattle
SB015733487252
SB1081
3
3
4
8
7
2
5
2
5
Cattle
SB015743437252
SB1081
4
3
4
3
7
2
5
2
6
Goat
SB015743487252
SB1078
4
3
4
8
7
2
5
2
7
Goat
SB108451395†354
SB1889
5
1
3
9
5†
3
5
4
8
Cattle
SB015743487252
SB1081
4
3
4
8
7
2
5
2
9
Cattle
SB041653386423
SB0157
4
3
4
8
7
2
5
2
10GoatSB097343
SB0157434925

*–, no amplification.
†Gel band of ≈1,800 bp. Sequencing showed that insertion sequence IS6110 is inserted within the third repetition of QUB11a.

*–, no amplification.
†Gel band of ≈1,800 bp. Sequencing showed that insertion sequence IS6110 is inserted within the third repetition of QUB11a. The routine application of molecular diagnosis and typing techniques in clinical laboratories has enabled its real role as a pathogen for several species to be recognized. In Spain, M. caprae represents 7.4% of all M. tuberculosis complex isolates from domestic and wild animals. Seventy-five of the 197 outbreaks (38.1%) involved goats (Table 1). This species showed the highest diversity among M. caprae with 12 patterns identified, 6 of them exclusive to caprine herds. The association of M. caprae with goats in Spain may be due to 2 reasons. First, the microorganism seems to be highly pathogenic for the goats in Spain, based on the disseminated tuberculous lesions that it produces and its fast transmission within a herd. Second, caprine herds have not been included in the national eradication campaign (except when coexisting with cattle or as part of some regional programs). Therefore, M. caprae infection can spread easily through animal movements, such as purchase for replacement or genetic improvement. The emergence of this pathogen in cattle has been observed. Cattle were involved in 106 outbreaks (53.3%) during the study period. Since 2004, cattle from 2,218 herds identified in the eradication program have been inspected by bacteriology. The number of cattle properties infected with M. caprae represented 0.85%–6.67% of the total number of herds diagnosed with bovine tuberculosis. Temporal trend of M. caprae isolates cultured over time was assessed by using the software WINPEPI 9.4 (). The proportion of M. caprae isolated from bovine samples has increased consistently during 2004–2009, showing a significant positive trend (p = 0.009, by Mantel trend test) (Figure 2). We observed more M. caprae infections in cattle in regions with a high goat density. However, an analysis of the type of farm production shows that 86.7% of M. caprae–infected cattle have been raised in farms without any contact with small ruminants. This fact indicates recirculation of the pathogen within and between cattle herds. In countries that are virtually free of animal tuberculosis such as Germany, Austria, and the Czech Republic, a large number of cases in cattle and red deer are caused by M. caprae.
Figure 2

Proportion and regression lines of Mycobacterium caprae isolates (black dots, continuous line) and M. caprae–infected herds (white triangles, dashed lines) of the total number of M. tuberculosis complex isolates and M. tuberculosis complex–infected herds identified in cattle during 2004–2009. Error bars indicate 95% confidence intervals.

Proportion and regression lines of Mycobacterium caprae isolates (black dots, continuous line) and M. caprae–infected herds (white triangles, dashed lines) of the total number of M. tuberculosis complex isolates and M. tuberculosis complex–infected herds identified in cattle during 2004–2009. Error bars indicate 95% confidence intervals. Identification of isolates from human patients has shown M. caprae as a human pathogen (,,). A recent study suggests that M. caprae causes 0.3% of the cases of human tuberculosis in Spain, with SB0157 also being the most dominant spoligotype (). The role of the pathogen as a public health risk is highlighted by lesions that can also be found in the mammary glands of infected goats; thus, consumption of unpasteurized dairy products remains a concern ().

Conclusions

Compelling evidence indicates that M. caprae poses a serious health risk not only for goats, but also for other domestic and wild animal species and humans. Our results indicate that M. caprae infection is widespread in Spain and that the epidemiology is driven by caprine infections. Considering the role of M. caprae in animal tuberculosis, relevant legislation should be considered to address the infection as was done for M. bovis.

Technical Appendix

Specific Characteristics.
  14 in total

1.  A case of urinary tuberculosis due to Mycobacterium bovis subspecies caprae.

Authors:  Vitali Sintchenko; Peter Jelfs; Michael Dally; Taryn Crighton; Gwendolyn L Gilbert
Journal:  Pathology       Date:  2006-08       Impact factor: 5.306

2.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

3.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Infection of red deer, cattle, and humans with Mycobacterium bovis subsp. caprae in western Austria.

Authors:  Wolfgang M Prodinger; Angelika Eigentler; Franz Allerberger; Michael Schönbauer; Walter Glawischnig
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001.

Authors:  Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats.

Authors:  R Frothingham; W A Meeker-O'Connell
Journal:  Microbiology       Date:  1998-05       Impact factor: 2.777

7.  Spoligotype diversity of Mycobacterium bovis and Mycobacterium caprae animal isolates.

Authors:  E L Duarte; M Domingos; A Amado; A Botelho
Journal:  Vet Microbiol       Date:  2008-02-26       Impact factor: 3.293

8.  Human tuberculosis due to Mycobacterium bovis and M. caprae in Spain, 2004-2007.

Authors:  E Rodríguez; L P Sánchez; S Pérez; L Herrera; M S Jiménez; S Samper; M J Iglesias
Journal:  Int J Tuberc Lung Dis       Date:  2009-12       Impact factor: 2.373

9.  High spoligotype diversity within a Mycobacterium bovis population: clues to understanding the demography of the pathogen in Europe.

Authors:  Sabrina Rodríguez; Beatriz Romero; Javier Bezos; Lucía de Juan; Julio Alvarez; Elena Castellanos; Nuria Moya; Francisco Lozano; Sergio González; José Luis Sáez-Llorente; Ana Mateos; Lucas Domínguez; Alicia Aranaz
Journal:  Vet Microbiol       Date:  2009-08-08       Impact factor: 3.293

10.  WINPEPI (PEPI-for-Windows): computer programs for epidemiologists.

Authors:  Joseph H Abramson
Journal:  Epidemiol Perspect Innov       Date:  2004-12-17
View more
  26 in total

1.  Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae.

Authors:  Bernat de Val Pérez; Sergio López-Soria; Miquel Nofrarías; Maite Martín; H Martin Vordermeier; Bernardo Villarreal-Ramos; Nadine Romera; Manel Escobar; David Solanes; Pere-Joan Cardona; Mariano Domingo
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

2.  Multilaboratory Evaluation of a Novel Lateral Flow Immunochromatographic Assay for Confirming Isolation of Mycobacterium bovis from Veterinary Diagnostic Specimens.

Authors:  Linda D Stewart; Lyanne McCallan; James McNair; Adrian McGoldrick; Rowan Morris; Jean-Louis Moyen; Lucía De Juan Ferré; Beatriz Romero; Elena Alonso; Sven D C Parsons; Paul Van Helden; Flábio R Araújo; Irene R Grant
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

3.  Genotypic characterization by spoligotyping and VNTR typing of Mycobacterium bovis and Mycobacterium caprae isolates from cattle of Tunisia.

Authors:  Hela Lamine-Khemiri; Remigio Martínez; Waldo Luis García-Jiménez; Jose Manuel Benítez-Medina; Maria Cortés; Inés Hurtado; Mohammed Salah Abassi; Imed Khazri; Mohammed Benzarti; Javier Hermoso-de-Mendoza
Journal:  Trop Anim Health Prod       Date:  2013-10-25       Impact factor: 1.559

4.  Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis.

Authors:  Bernat Pérez de Val; Bernardo Villarreal-Ramos; Miquel Nofrarías; Sergio López-Soria; Nadine Romera; Mahavir Singh; F Xavier Abad; Zhou Xing; H Martin Vordermeier; Mariano Domingo
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

5.  Spoligotype diversity and 5-year trends of bovine tuberculosis in Extremadura, southern Spain.

Authors:  Waldo L García-Jiménez; María Cortés; José M Benítez-Medina; Inés Hurtado; Remigio Martínez; Alfredo García-Sánchez; David Risco; Rosario Cerrato; Cristina Sanz; Miguel Hermoso-de-Mendoza; Pedro Fernández-Llario; Javier Hermoso-de-Mendoza
Journal:  Trop Anim Health Prod       Date:  2016-08-14       Impact factor: 1.559

6.  Region of difference 4 in alpine Mycobacterium caprae isolates indicates three variants.

Authors:  Janina Domogalla; Wolfgang M Prodinger; Helmut Blum; Stefan Krebs; Susanne Gellert; Matthias Müller; Erdmute Neuendorf; Florian Sedlmaier; Mathias Büttner
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

7.  Human Tuberculous Meningitis Caused by Mycobacterium caprae.

Authors:  Niels Hansen; Carola Seiler; Julian Rumpf; Peter Kraft; Henry Dlaske; Marianne Abele-Horn; Wolfgang Muellges
Journal:  Case Rep Neurol       Date:  2012-03-14

8.  Occurrence of non-tuberculous mycobacteria species in livestock from northern China and first isolation of Mycobacterium caprae.

Authors:  W Zeng; Y Zhang; X Zhao; G Huang; Y Jiang; H Dong; X Li; K Wan; C He
Journal:  Epidemiol Infect       Date:  2013-01-08       Impact factor: 4.434

9.  Occupational Exposure to Zoonotic Tuberculosis Caused by Mycobacterium caprae, Northern Greece, 2019.

Authors:  Dimitrios Papaventsis; George Dougas; Ourania Kalkouni; Simona Karabela; Katerina Manika
Journal:  Emerg Infect Dis       Date:  2021-08       Impact factor: 6.883

10.  Effects of vaccination against paratuberculosis on tuberculosis in goats: diagnostic interferences and cross-protection.

Authors:  Bernat Pérez de Val; Miquel Nofrarías; Sergio López-Soria; Joseba M Garrido; H Martin Vordermeier; Bernardo Villarreal-Ramos; Maite Martín; Eugenia Puentes; Ramón A Juste; Mariano Domingo
Journal:  BMC Vet Res       Date:  2012-10-16       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.